Advertisement
Screener

BIOVENTUS INC. (BVS) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

2.2 / 5 stars · 24/55 Roast Me

BIOVENTUS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

BIOVENTUS INC. (BVS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.05 million shares for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-05

  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-27 was 0.00 shares, a 100.00% decline year-over-year.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-28 was 1.05M shares, a 99.81% increase year-over-year.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 15.00K shares, a 79.17% decline year-over-year.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-27 was 0.00 shares.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 581.00K shares, a 68.34% decline from fiscal 2024.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.83M shares, a 49.67% increase from fiscal 2023.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.23M shares, a 52.95% decline from fiscal 2022.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 2.61M shares, a 69.13% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2026-06-270.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
1.05M shares
10-Q · filed 2026-08-05
1.06M shares
derived: sum of 3 quarters · filed 2026-08-05
1.06M shares
derived: sum of 4 quarters · filed 2026-08-05
2026-03-281.05M shares
10-Q · filed 2026-05-06
1.06M shares
derived: sum of 2 quarters · filed 2026-05-06
1.06M shares
derived: sum of 3 quarters · filed 2026-05-06
1.10M shares
derived: sum of 4 quarters · filed 2026-05-06
2025-12-3115.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
15.00K shares
derived: sum of 2 quarters · filed 2026-03-05
57.00K shares
derived: sum of 3 quarters · filed 2026-03-05
581.00K shares
10-K · filed 2026-03-05
2025-09-270.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
42.00K shares
derived: sum of 2 quarters · filed 2025-11-04
566.00K shares
10-Q · filed 2025-11-04
638.00K shares
derived: sum of 4 quarters · filed 2026-03-05
2025-06-2842.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
566.00K shares
10-Q · filed 2025-08-06
638.00K shares
derived: sum of 3 quarters · filed 2026-03-05
638.00K shares
derived: sum of 4 quarters · filed 2026-03-05
2025-03-29524.00K shares
10-Q · filed 2025-05-06
596.00K shares
derived: sum of 2 quarters · filed 2026-03-05
596.00K shares
derived: sum of 3 quarters · filed 2026-03-05
607.00K shares
derived: sum of 4 quarters · filed 2026-03-05
2024-12-3172.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
72.00K shares
derived: sum of 2 quarters · filed 2026-03-05
83.00K shares
derived: sum of 3 quarters · filed 2026-03-05
1.83M shares
10-K · filed 2026-03-05
2024-09-280.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
11.00K shares
derived: sum of 2 quarters · filed 2024-11-05
1.76M shares
10-Q · filed 2024-11-05
1.81M shares
derived: sum of 4 quarters · filed 2025-03-11
2024-06-2911.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
1.76M shares
10-Q · filed 2024-08-06
1.81M shares
derived: sum of 3 quarters · filed 2025-03-11
1.82M shares
derived: sum of 4 quarters · filed 2025-03-11
2024-03-301.75M shares
10-Q · filed 2024-05-07
1.80M shares
derived: sum of 2 quarters · filed 2025-03-11
1.80M shares
derived: sum of 3 quarters · filed 2025-03-11
2.96M shares
derived: sum of 4 quarters · filed 2025-03-11
2023-12-3144.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
53.00K shares
derived: sum of 2 quarters · filed 2025-03-11
1.20M shares
derived: sum of 3 quarters · filed 2025-03-11
1.23M shares
10-K · filed 2025-03-11
2023-09-309.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
1.16M shares
derived: sum of 2 quarters · filed 2023-11-07
1.18M shares
10-Q · filed 2023-11-07
1.22M shares
derived: sum of 4 quarters · filed 2024-03-12
2023-07-011.15M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
1.17M shares
10-Q · filed 2023-08-08
1.21M shares
derived: sum of 3 quarters · filed 2024-03-12
1.39M shares
derived: sum of 4 quarters · filed 2024-03-12
2023-04-0122.00K shares
10-Q · filed 2023-05-16
57.00K shares
derived: sum of 2 quarters · filed 2024-03-12
235.00K shares
derived: sum of 3 quarters · filed 2024-03-12
529.00K shares
derived: sum of 4 quarters · filed 2024-03-12
2022-12-3135.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12
213.00K shares
derived: sum of 2 quarters · filed 2024-03-12
507.00K shares
derived: sum of 3 quarters · filed 2024-03-12
2.61M shares
10-K · filed 2024-03-12
2022-10-01178.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21
472.00K shares
derived: sum of 2 quarters · filed 2022-11-21
2.57M shares
10-Q · filed 2022-11-21
2022-07-02294.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
2.39M shares
10-Q · filed 2022-08-12
2022-04-022.10M shares
10-Q · filed 2022-05-11
2021-12-318.44M shares
10-K · filed 2023-03-31
2021-10-0275.00K shares
10-Q · filed 2021-11-10
79.00K shares
derived: sum of 2 quarters · filed 2021-11-10
4.70M shares
derived: sum of 3 quarters · filed 2021-11-10
2021-07-034.00K shares
10-Q · filed 2021-11-10
4.63M shares
derived: sum of 2 quarters · filed 2021-11-10
2021-04-034.62M shares
10-Q · filed 2021-11-10